Analyst Price Target is $5.96
▲ +243.15% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Columbia Care in the last 3 months. The average price target is $5.96, with a high forecast of $8.37 and a low forecast of $4.50. The average price target represents a 243.15% upside from the last price of $1.74.
Current Consensus is
The current consensus among 2 contributing investment analysts is to buy stock in Columbia Care. This Buy consensus rating has held steady for over two years.
Columbia Care Inc. cultivates, manufactures, and provides cannabis products and related services. It offers flowers, edibles, oils, and tablets under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of June 15, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.